The clinical efficacy of a dermal formulation of Dimethicone in the treatment of plantar dermatitis in children aged two to six years

Phase 4

Recruiting

• Conditions: Juvenile Plantar Dermatitis, JPD.; Chronic bullous disease of childhood; L12.2

• Registration Number: IRCT20090808002306N9
• Lead Sponsor: Esfahan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 27 May 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

All children suffering from juvenile plantar dermatitis (Juvenile Plantar Dermatitis) with mild to moderate involvement who referred to dermatology clinics affiliated to Isfahan University of Medical Sciences between the fall of 1402 and the end of winter 1402 and met the entry criteria as described below. be: 2 to 6-year-old child with a clinical diagnosis of Juvenile Plantar Dermatitis (cracks, roughness, flaking, pain and burning in the soles of the feet)
Lack of evidence and history Contact dermatitisChemical
Absence of causes of fungal dermatophytic diseases of the skin
Not taking other medications to relieve cracking, scaling, pain and burning sensation in the soles of the feet during the last two weeks
Consent and informed consent of children's parents to enter this research project

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified